Ductus venosus is a tiny vessel with a central role in fetal circulation. Combining B-mode with color and pulsed Doppler is feasible to identify this vessel and evaluate the blood flow waveform at 11 to 13 weeks. The higher prevalence of abnormal A-wave in fetuses with abnormal karyotype and/or cardiac defects turned DV evaluation into a useful marker for chromosomal abnormalities and cardiopathies. Even when combined with nuchal translucency (NT) or biochemical markers, DV blood flow evaluation contributes to an increase in sensitivity and reduces false-positive rate. Abnormal ductal flow is also related to a worse fetal and perinatal outcome. In monochorionic twin pregnancies, in addition to NT measurement at 11 to 14 weeks, the Doppler assessment of DV blood flow increases relevantly the performance of screening for those at higher risk of developing twin-to-twin transfusion syndrome. This story of 14 years surely contributed to change the way first trimester screening is being implemented.
INTRODUCTION
Almost 20 years ago screening for fetal chromosomal and structural defects moved from the second to the first trimester of pregnancy, based on the measurement of fetal nuchal translucency (NT) thickness. It was well-established from epidemiological studies that increased NT was more prevalent among fetuses with trisomy 21 but the reason why NT was increased specifically in those babies was not clear. Several causes were suggested, such as lymphatic immaturity, mediastinal compression with venous congestion, fetal immobility, altered composition of the subcutaneous connective tissue and cardiac failure/dysfunction. Further exploring this last hypothesis, our group began a pioneering work on venous return evaluation in the first trimester of pregnancy. We came across a very tiny vein with arterial behavior that showed a very characteristic Doppler wave, the ductus venosus. However, in certain fetuses this vessel presented an abnormal wave that changed the whole picture of first trimester screening and gave birth to a successful story of 14 years.
Ductus Venosus: A Window into the Fetal Heart
Ductus venosus (DV) is the main distributor of placental blood and directs preferentially well-oxygenated blood from UV to the cerebral and coronary circulations, across the foramen ovale towards the left atrium (Lind et al, 1949; Kiserud et al, 1992a,b) . In fact, the venous return is arranged in a Y-shaped inferior vena cava-foramen ovale unit with two different pathways ( Fig. 1 ): • via sinistra (dorsal and left side stream): 30% (at midgestation) and 20% (at term) of umbilical blood is accelerated to the left atrium through the foramen ovale shunted from the DV and left hepatic veins (Kiserud 1992b ; Bellotti et al, 2000) .
• via dextra (ventral and rightward stream): 70% of less oxygenated blood enters the right ventricle through tricuspid valve, originating from inferior vena cava. The DV is located in the fetal abdomen, connecting the intra-abdominal ventral portion of umbilical sinus to the left side of the inferior vena cava, and streams caudocranially and ventrodorsally (Kiserud et al, 1991) (Fig. 2 ). It has a trumpetlike shape with the narrow portion (isthmus) measuring 0.5 mm at mid-gestation to about 2 mm in late-gestation; the outlet width increases from 1.25 to 3 mm and the length of the DV attains 20 mm at term (Kiserud et al, 1991 (Kiserud et al, , 1994a (Kiserud et al, , 1998 (Kiserud et al, , 2000a Mavrides et al, 2002) (Fig. 3 ).
Fig. 1:
Venous return is arranged in a Y-shaped inferior vena cavaforamen ovale unit with two different pathways (Courtesy: Prof Torvid Kiserud) Due to this architectural arrangement (sphincter-like), a pressure gradient is produced between the umbilical vein and the atrium, resulting in the acceleration of the blood flow in the DV and producing a triphasic high-velocity waveform (Kiserud et al, 1994) . Still the existence of this "sphincter" remains controversial: some studies have shown the presence of smooth muscle fibers at the inlet of the DV (Chacko et al, 1953; Ehinger et al, 1968) ; others have interpreted these smooth muscle fibers as part of the muscular arrangement of the umbilical and portal veins (Lind, 1977; Meyer et al, 1966) . More recently, Mavrides et al (2002) have shown the lack of an anatomical sphincter at the inlet that she described as narrow and rich in elastin. However, the presence of a single longitudinal layer of smooth muscle cells along the entire DV actively regulates the changes in diameter along the entire length of the vessel (Kiserud et al, 2000b) . These fibers are sensitive to changes in oxygen saturation and viscosity of the blood, with a 60% increase of the inlet diameter and distension of the entire vessel in response to hypoxemia (Kiserud et al, 2000b ).
Blood produces a very characteristic waveform through the DV when assessed by pulsed Doppler. An anterograde triphasic waveform is produced with a S-wave (ventricular systole), a D-wave (early diastole) and a A-wave (late diastole) ( Fig. 4 ). This latter wave presents the lowest velocity but always with forward flow (Kiserud et al, 1991) . The peak velocity attained in the A-wave is about 3 to 4 times the velocity in the umbilical vein. Unlike the second and third trimester, where the flow during the atrial contraction is always forward in normal pregnancies, one must take in consideration that in the early first trimester the A-wave can be null or reversed even in normal fetuses (Kiserud, 1999 (Kiserud, , 2003 . However, after 11 weeks a reversed A-wave is considered abnormal (Fig. 5 ). Therefore, an easy qualitative assessment can be performed in routine clinical practice classifying the A-wave as positive, absent or reversed (Matias et al, 1998) .
However, in order to quantify blood flow in the DV, several authors have suggested different indexes, such as pulsatility index for veins (PIV) (Hecher et al., 1994) Strict methodological principles should be adopted in order to obtain a reproducible and clinically relevant waveform. There is obviously a learning curve that implies the performance of 100 scans (Maiz et al, 2008a ).The technique indicated for first trimester assessment of DV blood flow which was first described by our group in 1997 (Montenegro et al, 1997) , assessing a right parasagittal plane by B-mode and taking care to avoid contamination by neighboring vessels (hepatic veins, inferior vena cava and umbilical vein) ( Fig. 6 ). The identification of the DV is greatly aided by using color Doppler putting the gate directly on the aliasing zone ( Fig. 7 ). Very comprehensive pictures can be obtained by tridimensional reconstruction (Fig. 8 ) and reviewed in necropsia specimens ( Fig. 9 ). The DV is distinguishable from the UV by a distinctly higher velocity. Even so, reproducibility studies held contradictory results. Most adequately, the bioeffects and safety of ultrasound in the first trimester of pregnancy were brought to discussion by Campbell and Platt (1999) with the outburst of Doppler studies early in pregnancy (Campbell and Platt, 1999) . Some reassurance was provided by strict guidelines to ensure the ALARA principle. Equipment should display safety indices, such as thermal index (TI) < 1.5 and mechanical index (MI) 
Mavrides et al (2001) reported a good intraobserver

Ductus venosus and its Role in the First Trimester Screening
Ductus venosus behaves like an "arterialized" vessel with a high pulsatile flow and forward velocities throughout the whole cardiac cycle. Therefore, it appears as the most useful vessel in assessing indirectly disturbed cardiac function (Montenegro et al, 1997; Matias et al, 1998 Matias et al, , 1999 . Quoting Torvid Kiserud in 1993, "the physiological position of the DV in the circulation, and its extraordinary hemodynamic properties and regulatory mechanisms make the tiny DV different from all other venous sections, carrying the potential of unique diagnostic information".
Chromosomal Abnormalities
Each pregnant woman presents a background or a priori risk (which depends on maternal age and gestational age) for chromosomal abnormalities, correctable individually by the combination of ultrasound or biochemical screening tests carried out during the course of the pregnancy.
Considering the trend to delayed childbearing with the consequent increase in the number of pregnant women > 35 years (20-25%), it is not feasible to offer invasive testing to all of them. In fact about half of the affected babies with trisomy 21 would be detected but at the expenses of a greatly increased false-positive rate.
Therefore, maternal age per se proved to be useless and at that time a big step forward was made when nuchal translucency (NT) was introduced in daily practice at 11 to 14 weeks of gestation (Nicolaides et al, 1992 ) and later combined with PAPP-A and B-HCG (Nicolaides, 2004; Nicolaides et al, 2005) .
In order to increase sensitivity (already set at 90%) and specificity, other complimentary tests were being searched. Our pioneering work in 1997 showed that a high proportion of fetuses with trisomy 21 and other chromosomal abnormalities had abnormal flow in the DV at 11 to 13 weeks of gestation (Montenegro et al, 1997) . Combining data from nine posterior studies, abnormal blood flow in the DV was observed in 5.2% of euploid fetuses and 70.8, 89.3, 81.8 and 76.9% of fetuses with trisomies 21, 18 and 13 and Turner syndrome respectively ( Table 2) Several papers along these 14 years yielded strong evidence for the satisfactory performance of DV assessment in the 1st trimester of pregnancy: Among 6,653 women tested for DV blood flow between 10 to 13 weeks, the detection rate for aneuploidies was 88% (Comas et al, 2001). Zoppi et al (2002) showed that the probability of having a chromosomal abnormality in a fetus with enlarged NT was greater when an abnormal A-wave in the DV was found. Mavrides et al (2002) reported that an abnormal flow in the DV increased the risk of fetal aneuploidy by about 10 times. The pulsatility index of DV was 1.7× higher in fetuses with trisomy 21 (Borrell et al, 2005) . The likelihood ratio for trisomy 21 was 7.05 in the case of abnormal DV and 6.42 for absent nasal bones (Prefumo et al, 2005) . The finding of an abnormal A-wave in the DV was observed in 3.2% of euploid fetuses and 66.4% of fetuses with trisomy 21 (Maiz et al, 2009 ). More recently, in a cohort study, 80% of all chromosomal anomalies were identified by an increased DVPIV and 68% by an abnormal A-wave. The odds of chromosomal anomalies increased by a factor 4. The exact reason for an abnormal A-wave in the DV in association with trisomy 21 is yet not entirely clear. However, it is likely that this abnormality is not a result of a change in the DV itself but rather due to a change in the fetal heart performance. The first trimester fetal heart has special structural and functional conditions that explain this reversal of A-wave only during this temporal window: Fetal myocardium is stiffer and less compliant; A-wave (atrial contraction) is preponderant over E-wave (passive filling) and there is high afterload (increased placental resistance).
Therefore, the mechanical explanation for the A-wave reversal may be that the atrial wall is contracting against a relatively stiffer wall with a consequent increased back pressure that would be sufficient to either stop or reverse the blood flow during atrial systole (absent or reversed A-wave). . Routine echocardiography is also not feasible considering this is a time consuming and technically differentiated diagnostic tool. It is common sense that detecting this kind of pathology prenatally allows the effective and timely planning of delivery in a tertiary center (Khoshnood et al, 2005) . Therefore, the selection of a 'high-risk' group not only is based on maternal medical and obstetric history but also a family history of congenital heart disease would be dramatically useful.
In an attempt to address this issue, our group proposed in 1999 the evaluation of DV blood flow as one possible screening method for cardiac defects in the first trimester of pregnancy that could improve the role of increased NT in chromosomally normal fetuses (Matias et al, 1999) . Combining data from eight studies that examined DV waveforms in chromosomally normal fetuses with increased NT thickness, a major cardiac defect was detected in 96.6% of those with abnormal Doppler waveforms in the DV (Table 3) Going into greater detail, Haak et al (2003) found abnormal ductal flow in 80% of the fetuses with increased NT that were chromosomally abnormal but with a normal heart, but in all fetuses with abnormal heart irrespective of the karyotype. In the same year, Favre et al reported that DV blood flow evaluation was as sensitive as NT in the detection of cardiac defects but far more specific (Favre et al, 2003) . In a recent paper, Maiz referred that the risk of a cardiac defect is threefold increased if DV presents an abnormal flow, but is halved if the ductal flow is normal (Maiz et al, 2008) . More recently, Martinez et al (2011) scanned a low risk population and found abnormal flow in 3.5% of the fetuses. Among those fetuses with reversed A-wave and normal karyotype, 11 CHD were diagnosed, yielding a sensitivity of 24.4% and an odds ratio of 9.4. In this study, the use of DV increased early detection of CHD by 11% with respect to the use of NT alone. Therefore, in experienced hands, the authors suggest that abnormal DV in the first trimester can be an independent predictor of CHD and should constitute an indication for early echocardiography (Martinez et al, in press ).
Pregnancy Loss
It is well known that the risk of pregnancy loss increases with advanced gestational and maternal age, poor obstetric history, obesity Abnormal flow in the DV has also been associated with adverse perinatal outcome and fetal death. Toyama et al found a prevalence of fetal death of 22% in the abnormal DV flow group when compared to 6% in the normal outcome group (Toyama et al, 2004) . A case-control study of fetuses with normal NT showed that in 23.8% of cases with abnormal flow in the DV an adverse outcome was recorded, including perinatal death and chromosomal, cardiac or non-cardiac abnormalities (Oh et al, 2007) .
Major Fetal Abnormalities
A detailed fetal anatomy examination is part of the 11 to 13 weeks scan (Souka et al, 2004) . Increased NT has been associated with a huge number of fetal abnormalities and syndromes (Souka et al, 2006) . In the majority of the studies assessing the association of abnormal DV flow and chromosomal abnormalities or cardiac defects there is reference to non-cardiac structural abnormalities (Table 4) .
Twin-to-Twin Transfusion Syndrome (TTTS)
Monochorionic (MC) twin pregnancies frequency has been increasing in the last 20 years, placing a heavy burden in the twins' perinatal morbidity and mortality rates (Sebire et al, 1997a; Acosta-Rojas et al, 2007) . Considering the shared placental territory and the nearly universal presence of intertwin anastomoses, we can understand TTTS as a rather common event that can endanger the course of those pregnancies. We also believe that the sooner the diagnosis of TTTS, the most efficacious the treatment is expected to be. It would be helpful for patients counseling and management if MC pregnancies at high risk for fetal complications could be predicted accurately in early pregnancy.
Therefore, several screening models have been proposed to predict the occurrence of TTTS prior to 18 weeks and anticipate the implicated hemodynamic imbalance as early as the first trimester of pregnancy, such as NT discrepancy (Sebire et al, 1997b (Sebire et al, , 2000 Kagan et al, 2007; Lewi et al, 2008) or crown-rump length discrepancy (Casabuenas et al, 2007) or intertwin membrane folding (Sebire et al, 1998) . However, both sonographic markers have a high false-positive rate and none has provided a meaningful sensitivity with useful clinical application in the screening of TTTS. In fact, increased NT in at least one of the fetuses at 11 to 14 weeks has been associated with a 3.5 fold increased risk of TTTS, although the detection rate was only about 30% with a false-positive rate of 10% (Sebire et al, 2000) . Similarly, intertwin discordance in NT thickness was proposed as a screening method to identify pregnancies at a higher risk of TTTS. If the discordance is > 20%, about one third of the pregnancies will eventually develop TTTS or end up in fetal death, while if the discordance is < 20% these occurrences decrease to 10% (Kagan et al, 2007) .
Addressing the issue of early fetal hemodynamic compromise, our group provided preliminary evidence that abnormal flow in the DV at 11 to 13+6 weeks of gestation in singletons is associated with increased risk of chromosomal abnormalities (Matias et al, 1998 . It would clearly be a major advance if the sequence of events could be anticipated as early as the first trimester of pregnancy based on indirect signs of hemodynamic compromise. Thus, this rationale was applied with promising results to MC twins that eventually developed TTTS (Matias et al, 2000 (Matias et al, , 2005 , considering that monochorionic pregnancies are not related to a higher prevalence of chromosomal abnormalities.
More recently, in a more inclusive study, we showed that discrepant values for NT over 0.6 mm had a sensitivity of 45.5% and a specificity of 86.9%. The presence of at least one abnormal blood flow waveform in the DV translated in a relative risk for developing TTTS of 11.86 (95% CI, 3.05-57.45) with a sensitivity of 72.7% and a specificity of 91.7% ( Table 5 ). The Therefore, both increased nuchal translucency and abnormal flow in the DV in monochorionic twins may translate early manifestations of hemodynamic imbalance between donor and recipient. In these pregnancies, in addition to NT measurement at 11 to 14 weeks, the Doppler assessment of DV blood flow increases relevantly the performance of screening for those at risk of developing twin-to-twin transfusion syndrome.
CONCLUSION
Over the past 40 years, the use of ultrasound has been clearly established as an indispensable tool in obstetric management. The improvement in the quality of the ultrasound equipment and the more profound knowledge of fetal physiology moved the time of screening and diagnosis to an earlier point in pregnancy. The increased performance of ultrasonographic and biochemical markers improved the sensitivity and decreased the false-positive rates as well as the invasive testing rate, improving the capabilities of the first trimester scan.
The large contribution of DV flow assessment in the improvement of the performance of screening for chromosomal abnormalities is now well-established in more than 25,000 cases. It also proved useful in the early screening of cardiac defects, identifying a subgroup of higher risk with indication for a specialized echocardiography. Performing successfully in the prediction of twin-to-twin transfusion syndrome in monochorionic twin pregnancies, it helps to modify the intensity of fetal surveillance in those fetuses more prone to develop the syndrome. This story of 14 years surely contributed to change the way first trimester screening is being implemented.
